Jared Lunceford

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

Edward B. Garon, Naiyer A. Rizvi, Rina Hui et al. · New England Journal of Medicine · 2015 · 6.1K citations · Full text

IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade

Mark Ayers, Jared Lunceford, Michael Nebozhyn et al. · Journal of Clinical Investigation · 2017 · 3.7K citations · Full text

Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy

Răzvan Cristescu, Robin Mogg, Mark Ayers et al. · Science · 2018 · 2.3K citations

Checkpoint Blockade Immunotherapy, Immunology, Immune Cell Therapy +16

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

Tanguy Y. Seiwert, Barbara Burtness, Ranee Mehra et al. · The Lancet Oncology · 2016 · 1.7K citations

Phase 1B, Medicine, Pathology +6

Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study

Jared Lunceford, Marie Davidian · Statistics in Medicine · 2004 · 1.7K citations

Treatment Effect, Treatment Exposure Conditional, Quasi-experiment +21